How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer
about
AZD1480 blocks growth and tumorigenesis of RET- activated thyroid cancer cell linesQuantitative analysis of receptor tyrosine kinase-effector coupling at functionally relevant stimulus levels.Profile of cabozantinib and its potential in the treatment of advanced medullary thyroid cancer.MK-2206 causes growth suppression and reduces neuroendocrine tumor marker production in medullary thyroid cancer through Akt inhibition.Corrigendum to "How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer".Evolving paradigms for successful molecular imaging of medullary thyroid carcinoma
P2860
How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
How to Treat a Signal? Current ...... nt of Medullary Thyroid Cancer
@en
How to Treat a Signal? Current ...... t of Medullary Thyroid Cancer.
@nl
type
label
How to Treat a Signal? Current ...... nt of Medullary Thyroid Cancer
@en
How to Treat a Signal? Current ...... t of Medullary Thyroid Cancer.
@nl
prefLabel
How to Treat a Signal? Current ...... nt of Medullary Thyroid Cancer
@en
How to Treat a Signal? Current ...... t of Medullary Thyroid Cancer.
@nl
P2860
P50
P356
P1476
How to Treat a Signal? Current ...... nt of Medullary Thyroid Cancer
@en
P2093
Fernando Rodrigues
Joana P Couto
P2860
P304
P356
10.4061/2011/678357
P577
2011-06-23T00:00:00Z